Articles by Susan Haigney - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Susan Haigney

Moving Toward a Safer Supply Chain

FDAs Secure Supply Chain Pilot Program, RX-360, and other industry efforts advance actions to secure the drug supply chain.
Aug 4, 2014

FDA's Secure Supply Chain Pilot Program, RX-360, and other industry efforts advance actions to secure the drug supply chain.

Securing the Supply Chain

Regulators and industry leaders take on the task of securing the drug supply chain.
Jul 2, 2014

Regulators and industry leaders take on the task of securing the drug supply chain.

Challenges in Managing the Cold Chain

Industry experts discuss challenges in managing the cold chain.
Dec 11, 2013

Industry experts discuss challenges in managing the cold chain.

Implementing QbD in Sterile Manufacturing

Industry experts discuss the application, challenges, and benefits of a quality-by-design approach to sterile manufacturing.
Dec 2, 2013

Industry experts discuss the application, challenges, and benefits of a quality-by-design approach to sterile manufacturing.

FDA Creates Partnership to Battle Anti-Malaria Counterfeit Drugs

Apr 24, 2013

FDA will use a new anticounterfeiting tool to detect fake medicines.

Compounding Pharmacies Recall Products

Apr 16, 2013

FDA inspections of compounding pharmacies manufacturing sterile-drug products lead to voluntary recalls.

FDA Commissioner Claims Resistance to Compounding Pharmacy Inspections

Apr 12, 2013

FDA inspections of compounding pharmacies manufacturing sterile products reveal non-sterile conditions.

FDA Requests Almost $5 Billion for 2014 Budget

Apr 12, 2013

FDA's Fiscal Year 2014 budget request includes more than $10 million above the 2012 budget for inspections of products manufactured in China.

FDA Releases SUPAC Guidance

Apr 2, 2013

Draft guidance combines and supersedes previous guidance documents.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here